Loading...
XSHG
688098
Market cap362mUSD
Jul 16, Last price  
6.39CNY
1D
3.06%
1Q
13.50%
IPO
-76.16%
Name

Shanghai Shen Lian Biomedical Corp

Chart & Performance

D1W1MN
No data to show
P/E
82.62
P/S
8.64
EPS
0.08
Div Yield, %
0.55%
Shrs. gr., 5y
3.18%
Rev. gr., 5y
1.85%
Revenues
301m
-8.25%
193,093,762203,652,967240,922,685267,705,441302,075,997275,137,414253,809,330337,732,400358,429,248328,594,513301,487,059
Net income
32m
-48.42%
41,823,38561,140,41075,843,83573,471,83998,677,95487,580,33277,957,157129,514,301110,201,86261,101,43631,518,678
CFO
4m
-61.21%
51,788,300105,978,10030,862,50047,995,28774,605,137121,129,68253,812,891111,730,33890,119,9839,088,1883,525,531
Dividend
Jun 14, 20240.035 CNY/sh

Profile

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
URL
http://www.slbio.com.cn/
IPO date
Oct 28, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
301,487
-8.25%
328,595
-8.32%
Cost of revenue
242,392
221,254
Unusual Expense (Income)
NOPBT
59,095
107,341
NOPBT Margin
19.60%
32.67%
Operating Taxes
6,415
13,580
Tax Rate
10.85%
12.65%
NOPAT
52,680
93,761
Net income
31,519
-48.42%
61,101
-44.55%
Dividends
(32,774)
(36,958)
Dividend yield
1.11%
1.13%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
334
136
Long-term debt
1,834
620
Deferred revenue
9,488
10,364
Other long-term liabilities
1
1
Net debt
(44,393)
(357,109)
Cash flow
Cash from operating activities
3,526
9,088
CAPEX
(129,632)
Cash from investing activities
21,864
36,009
Cash from financing activities
(33,142)
FCF
(62,415)
(13,129)
Balance
Cash
207,351
357,865
Long term investments
(160,790)
Excess cash
31,487
341,435
Stockholders' equity
978,332
968,138
Invested Capital
1,486,320
1,153,136
ROIC
3.99%
8.61%
ROCE
3.89%
7.18%
EV
Common stock shares outstanding
393,983
410,644
Price
7.48
-5.79%
7.94
-28.08%
Market cap
2,946,996
-9.62%
3,260,513
-28.08%
EV
2,920,939
2,903,404
EBITDA
122,546
164,409
EV/EBITDA
23.84
17.66
Interest
36
12,677
Interest/NOPBT
0.06%
11.81%